[Genetics of dilated cardiomyopathy]

Area of Science:

• Cardiology
• Genetics
• Molecular Biology

Background:

• Dilated cardiomyopathy (DCM) is a major cause of heart failure and heart transplantation, particularly in young adults.
• Etiology is often unknown, with chronic inflammation, alcohol abuse, and genetic factors implicated.
• Familial inheritance accounts for 25-30% of DCM cases, primarily autosomal dominant.

Purpose of the Study:

• To review the known genetic causes of dilated cardiomyopathy.
• To explore the relationship between genetic mutations and clinical manifestations.
• To hypothesize about the underlying pathophysiology of DCM based on identified genes.

Main Methods:

• Review of prospective studies on relatives of DCM patients.
• Analysis of identified disease genes and their associated mutations.
• Correlation of genetic findings with clinical phenotypes and inheritance patterns.

Main Results:

• Eight DCM disease genes identified: dystrophin, tafazzin, cardiac actin, desmin, lamin A/C, delta-sarcoglycan, cardiac beta-myosin heavy chain, and cardiac troponin T.
• Specific mutations linked to DCM, conduction system disease, skeletal myopathy, and syndromic presentations (e.g., Barth syndrome).
• Autosomal dominant inheritance is most common, followed by X-linked and rare autosomal recessive/mitochondrial transmission.

Conclusions:

• Dilated cardiomyopathy has a significant genetic component, with numerous genes identified.
• Understanding these genes provides insights into myocardial function and potential therapeutic targets.
• Further research into disease loci and gene function is crucial for improved diagnostics and treatments.